Skip to main content
Fig. 2 | European Journal of Medical Research

Fig. 2

From: Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case–control study

Fig. 2

Comparison of the steady-state plasma concentrations of pyrimethamine (a) and sulfadiazine (b) in pregnant women (PT; N = 89) and in women with ocular toxoplasmosis (OT; N = 17). Red lines: lower and upper target concentrations of pyrimethamine (700 and 1300 µg/l)14 and sulfadiazine (50 and 150 mg/l)21

Back to article page